China Biotech Services Holdings
China Biotech Services Holdings, often referred to as CBSH, is a prominent player in the medical, precision, and optical instruments sector, headquartered in China (CN). Established in 2000, the company has made significant strides in providing innovative solutions within the biotechnology and healthcare industries.
With a focus on precision instruments and advanced medical technologies, CBSH offers a range of core products and services that stand out for their quality and reliability. The company has established a strong market position, recognised for its commitment to research and development, which has led to notable achievements in enhancing healthcare delivery.
Operating primarily in China, CBSH continues to expand its influence in the Asia-Pacific region, contributing to advancements in medical diagnostics and treatment methodologies. Its dedication to excellence and innovation solidifies its reputation as a leader in the biotechnology services landscape.
-11 vs industry average
China Biotech Services Holdings’s score of 17 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at China Biotech Services Holdings?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
China Biotech Services Holdings's reported carbon emissions
China Biotech Services Holdings, headquartered in China and operating within the medical, precision and optical instruments, watches and clocks sector, reported total carbon emissions of approximately 843,000 kg CO2e for the fiscal year 2023. This figure encompasses Scope 2 emissions totalling around 647,000 kg CO2e and Scope 3 emissions of approximately 63,700 kg CO2e, with business travel accounting for about 48,000 kg CO2e and waste generated in operations for about 5,600 kg CO2e.
In the preceding year, 2022, the company's total emissions were approximately 11,273,000 kg CO2e. This included Scope 2 emissions of about 11,237,000 kg CO2e and Scope 3 emissions of roughly 33,700 kg CO2e, with business travel at approximately 15,600 kg CO2e and waste generated in operations at about 11,600 kg CO2e.
For 2021, China Biotech Services Holdings reported total emissions of approximately 238,000 kg CO2e, comprising Scope 1 emissions of about 38,000 kg CO2e, Scope 2 emissions of around 159,000 kg CO2e, and Scope 3 emissions of approximately 40,900 kg CO2e. Key Scope 3 components for this year included business travel (about 13,100 kg CO2e), processing of sold products (around 6,000 kg CO2e), and waste generated in operations (approximately 21,800 kg CO2e).
In 2020, total emissions were approximately 465,000 kg CO2e, with Scope 1 at about 35,000 kg CO2e, Scope 2 at around 339,000 kg CO2e, and Scope 3 at approximately 30,900 kg CO2e. Scope 3 activities included business travel (around 5,600 kg CO2e), processing of sold products (approximately 6,100 kg CO2e), and waste generated in operations (about 19,200 kg CO2e).
The company's total emissions for 2019 were approximately 541,000 kg CO2e, with Scope 1 at around 30,000 kg CO2e, Scope 2 at about 467,000 kg CO2e, and Scope 3 at approximately 43,700 kg CO2e. Scope 3 emissions in 2019 were largely attributed to business travel (about 23,200 kg CO2e) and waste generated in operations (around 19,300 kg CO2e).
China Biotech Services Holdings has not disclosed specific quantitative reduction targets or commitments to initiatives such as the Science Based Targets initiative (SBTi) or the Climate Pledge within the provided data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
China Biotech Services Holdings’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for China Biotech Services Holdings yet.
Scope 3 top emissions categories
2 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
China Biotech Services Holdings
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project